BR9908280A - Phospholipase enzyme inhibitors - Google Patents
Phospholipase enzyme inhibitorsInfo
- Publication number
- BR9908280A BR9908280A BR9908280-2A BR9908280A BR9908280A BR 9908280 A BR9908280 A BR 9908280A BR 9908280 A BR9908280 A BR 9908280A BR 9908280 A BR9908280 A BR 9908280A
- Authority
- BR
- Brazil
- Prior art keywords
- enzyme inhibitors
- phospholipase
- phospholipase enzyme
- disclosed
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
Patente de Invenção: <B>"INIBIDORES DE ENZIMAS DE FOSFOLIPASE"<D>. São revelados novos compostos que inibem a atividade de enzimas de fosfolipase, particularmente fosfolipase citosólida A~ 2~. Composições farmacêuticas compreendendo tais compostos e métodos de tratamento usando-se tais composições são também reveladas.Invention Patent: <B> "PHOSPHOLIPASE ENZYME INHIBITORS" <D>. New compounds are disclosed that inhibit the activity of phospholipase enzymes, particularly cytosolid A ~ 2 ~ phospholipase. Pharmaceutical compositions comprising such compounds and methods of treatment using such compositions are also disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3006298A | 1998-02-25 | 1998-02-25 | |
PCT/US1999/003899 WO1999043651A2 (en) | 1998-02-25 | 1999-02-24 | Inhibitors of phospholipase enzymes |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9908280A true BR9908280A (en) | 2000-10-31 |
Family
ID=21852314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9908280-2A BR9908280A (en) | 1998-02-25 | 1999-02-24 | Phospholipase enzyme inhibitors |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1056719A2 (en) |
JP (1) | JP2002504539A (en) |
KR (1) | KR20010041343A (en) |
CN (1) | CN1299347A (en) |
AU (1) | AU2782699A (en) |
BG (1) | BG104780A (en) |
BR (1) | BR9908280A (en) |
CA (1) | CA2322161A1 (en) |
EA (1) | EA200000868A1 (en) |
EE (1) | EE200000486A (en) |
HR (1) | HRP20000552A2 (en) |
HU (1) | HUP0100757A3 (en) |
ID (1) | ID27280A (en) |
IL (1) | IL137718A0 (en) |
NO (1) | NO20004220L (en) |
PL (1) | PL342995A1 (en) |
SK (1) | SK12742000A3 (en) |
TR (1) | TR200002446T2 (en) |
WO (1) | WO1999043651A2 (en) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60009480T2 (en) * | 1999-05-05 | 2005-09-01 | Aventis Pharma Ltd., West Malling | UREAES AS MODULATORS OF CELL ADHESION |
AU2001277056B2 (en) | 2000-07-25 | 2005-09-29 | Merck & Co., Inc. | N-substituted indoles useful in the treatment of diabetes |
ES2376161T3 (en) | 2001-01-29 | 2012-03-09 | Janssen Pharmaceuticals, Inc. | SUBSTITUTE INDOLES AND THEIR USE AS AN INTEGRINE ANTAGONISTS. |
US20030013846A1 (en) | 2001-05-03 | 2003-01-16 | Bing Wang | Pyruvate derivatives |
US6608196B2 (en) | 2001-05-03 | 2003-08-19 | Galileo Pharmaceuticals, Inc. | Process for solid supported synthesis of pyruvate-derived compounds |
US7291639B2 (en) | 2001-06-20 | 2007-11-06 | Wyeth | Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
DK1397130T3 (en) | 2001-06-20 | 2007-11-12 | Wyeth Corp | Substituted Indole Acid Derivatives as Inhibitors of Plasminogen Activator Inhibitor-1 (PAI-1) |
TWI224101B (en) | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
US7189751B2 (en) * | 2001-06-25 | 2007-03-13 | Nippon Soda Co., Ltd. | Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
US6797708B2 (en) | 2001-12-03 | 2004-09-28 | Wyeth | Inhibitors of cytosolic phospholipase A2 |
ES2300490T3 (en) * | 2001-12-03 | 2008-06-16 | Wyeth | CITOSOLICA A2 PHOSPHOLIPASE INHIBITORS. |
US6984735B2 (en) | 2001-12-03 | 2006-01-10 | Wyeth | Process for making an aldehyde |
US7101875B2 (en) | 2001-12-03 | 2006-09-05 | Wyeth | Methods for treating arthritic disorders |
US7605156B2 (en) | 2001-12-03 | 2009-10-20 | Wyeth | Methods for the use of inhibitors of cytosolic phospholipase A2 |
US7713964B2 (en) | 2001-12-03 | 2010-05-11 | Wyeth Llc | Methods for treating asthmatic conditions |
SI1451154T1 (en) * | 2001-12-03 | 2008-06-30 | Wyeth Corp | Inhibitors of cytosolic phospholipase a2 |
US6635771B2 (en) | 2001-12-03 | 2003-10-21 | Wyeth | N-benzhydryl indole compounds |
AUPS282602A0 (en) | 2002-06-07 | 2002-06-27 | Garvan Institute Of Medical Research | Method of inhibiting cell proliferation |
WO2004020409A1 (en) | 2002-08-29 | 2004-03-11 | Merck & Co., Inc. | Indoles having anti-diabetic activity |
JP4340232B2 (en) | 2002-08-29 | 2009-10-07 | メルク エンド カムパニー インコーポレーテッド | Indoles having anti-diabetic activity |
US7795280B2 (en) | 2002-11-07 | 2010-09-14 | N.V. Organon | Indoles useful in the treatment of androgen-receptor related diseases |
CN1723198A (en) | 2002-12-10 | 2006-01-18 | 惠氏公司 | Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
CN1726191A (en) | 2002-12-10 | 2006-01-25 | 惠氏公司 | Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
UA80453C2 (en) | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
DK1569900T3 (en) | 2002-12-10 | 2006-10-23 | Wyeth Corp | Substituted 3-carbonyl-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
EP1569899B1 (en) | 2002-12-10 | 2006-06-28 | Wyeth | Substituted 3-alkyl- and 3-arylalkyl-1h-indol-1-yl-acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
TW200510305A (en) * | 2003-07-25 | 2005-03-16 | Wyeth Corp | Process for the preparation of CPLA2 inhibitors |
US7446201B2 (en) | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
US7420083B2 (en) | 2003-09-25 | 2008-09-02 | Wyeth | Substituted aryloximes |
US7411083B2 (en) | 2003-09-25 | 2008-08-12 | Wyeth | Substituted acetic acid derivatives |
US7265148B2 (en) | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
US7268159B2 (en) | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
US7141592B2 (en) | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
US7351726B2 (en) | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
US7163954B2 (en) | 2003-09-25 | 2007-01-16 | Wyeth | Substituted naphthyl benzothiophene acids |
US7582773B2 (en) | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
US7332521B2 (en) | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
US7442805B2 (en) | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
US7342039B2 (en) | 2003-09-25 | 2008-03-11 | Wyeth | Substituted indole oximes |
GB0324763D0 (en) | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
TW200602317A (en) | 2004-04-23 | 2006-01-16 | Akzo Nobel Nv | Novel androgens |
AU2005254782A1 (en) | 2004-06-18 | 2005-12-29 | Biolipox Ab | Indoles useful in the treatment of inflammation |
MX2007002178A (en) | 2004-08-23 | 2007-04-02 | Wyeth Corp | Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases. |
ATE399156T1 (en) * | 2004-10-27 | 2008-07-15 | Hoffmann La Roche | NEW INDOLE OR BENZIMIDAZOLE DERIVATIVES |
DE602005026867D1 (en) * | 2005-01-19 | 2011-04-21 | Biolipox Ab | INFLAMMATORY INDOL DERIVATIVES |
WO2007024294A2 (en) | 2005-05-03 | 2007-03-01 | Cgi Pharmaceuticals, Inc. | Certain substituted ureas, as modulators of kinase activity |
GT200600228A (en) * | 2005-05-27 | 2006-12-26 | INHIBITORS OF PHOSPHOLIPASE A2 CITOSOLICA | |
AU2006279496A1 (en) | 2005-08-17 | 2007-02-22 | Wyeth | Substituted indoles and use thereof |
GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
WO2009093029A1 (en) | 2008-01-22 | 2009-07-30 | Oxagen Limited | Compounds having crth2 antagonist activity |
AR072297A1 (en) | 2008-06-27 | 2010-08-18 | Novartis Ag | DERIVATIVES OF INDOL-2-IL-PIRIDIN-3-ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE SYNTHESIS ALDOSTERONE. |
AR077280A1 (en) | 2009-06-29 | 2011-08-17 | Incyte Corp | PYRIMIDINONES AS PI3K INHIBITORS, AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM |
WO2011075643A1 (en) | 2009-12-18 | 2011-06-23 | Incyte Corporation | Substituted heteroaryl fused derivatives as pi3k inhibitors |
EP2558463A1 (en) | 2010-04-14 | 2013-02-20 | Incyte Corporation | Fused derivatives as i3 inhibitors |
US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
TW201249844A (en) | 2010-12-20 | 2012-12-16 | Incyte Corp | N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors |
WO2012125629A1 (en) | 2011-03-14 | 2012-09-20 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors |
WO2012135009A1 (en) | 2011-03-25 | 2012-10-04 | Incyte Corporation | Pyrimidine-4,6-diamine derivatives as pi3k inhibitors |
SI2751109T1 (en) | 2011-09-02 | 2017-03-31 | Incyte Holdings Corporation | Heterocyclylamines as pi3k inhibitors |
AR090548A1 (en) | 2012-04-02 | 2014-11-19 | Incyte Corp | BICYCLIC AZAHETEROCICLOBENCILAMINS AS PI3K INHIBITORS |
JP6106746B2 (en) | 2012-07-17 | 2017-04-05 | グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited | Indolecarbonitriles as selective androgen receptor modulators |
GB201322273D0 (en) | 2013-12-17 | 2014-01-29 | Atopix Therapeutics Ltd | Process |
WO2015191677A1 (en) | 2014-06-11 | 2015-12-17 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors |
CN117800973A (en) | 2015-02-27 | 2024-04-02 | 因赛特控股公司 | Salts of PI3K inhibitors and methods of making the same |
WO2016183060A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
EP3860998B1 (en) | 2018-10-05 | 2023-12-27 | Annapurna Bio Inc. | Compounds and compositions for treating conditions associated with apj receptor activity |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE314373B (en) * | 1966-04-12 | 1969-09-08 | Sumitomo Chemical Co | |
FR1492929A (en) * | 1966-05-11 | 1967-08-25 | Roussel Uclaf | Novel substituted 1- (omega-carboxyalkyl) indoles and method of preparation |
US3505354A (en) * | 1967-05-18 | 1970-04-07 | Geigy Chem Corp | 2-methyl-3-p-halobenzoylindole-n-aliphatic acids |
DE1816335A1 (en) * | 1968-12-21 | 1970-07-09 | Thiemann Gmbh Chem Pharm Fabri | 2-methyl-5-alkoxy-3-acyl-indole-1-acetic - acid and esters thereof |
US4894386A (en) * | 1987-04-15 | 1990-01-16 | Ici Americas Inc. | Aliphatic carboxamides |
DE68904342T2 (en) * | 1988-04-13 | 1993-05-06 | Ici America Inc | CYCLIC AMIDES. |
US5420289A (en) * | 1989-10-27 | 1995-05-30 | American Home Products Corporation | Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase |
US5290798A (en) * | 1991-09-30 | 1994-03-01 | Merck Frosst Canada, Inc. | (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
DK0640080T3 (en) * | 1992-05-13 | 1998-05-25 | Syntex Inc | Substituted indoles as angiotensin II antagonists |
IL109311A0 (en) * | 1993-04-16 | 1994-07-31 | Lilly Co Eli | 1H-indole-3-acetamide sPla2 inhibitors |
DE4338770A1 (en) * | 1993-11-12 | 1995-05-18 | Matthias Dr Lehr | Indole-2-alkanoic acids and their derivatives as inhibitors of phospholipase A¶2¶ |
ATE255090T1 (en) * | 1996-08-01 | 2003-12-15 | Merckle Gmbh | ACYLPYRROLDICARBONONIC ACIDS AND ACYLINDOLICARBONONIC ACIDS AND THEIR DERIVATIVES AS INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 |
AU717430B2 (en) * | 1996-08-26 | 2000-03-23 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
-
1999
- 1999-02-24 EP EP99908379A patent/EP1056719A2/en not_active Withdrawn
- 1999-02-24 IL IL13771899A patent/IL137718A0/en unknown
- 1999-02-24 SK SK1274-2000A patent/SK12742000A3/en unknown
- 1999-02-24 PL PL99342995A patent/PL342995A1/en unknown
- 1999-02-24 AU AU27826/99A patent/AU2782699A/en not_active Abandoned
- 1999-02-24 CA CA002322161A patent/CA2322161A1/en not_active Abandoned
- 1999-02-24 CN CN99805385A patent/CN1299347A/en active Pending
- 1999-02-24 BR BR9908280-2A patent/BR9908280A/en not_active IP Right Cessation
- 1999-02-24 JP JP2000533409A patent/JP2002504539A/en not_active Withdrawn
- 1999-02-24 WO PCT/US1999/003899 patent/WO1999043651A2/en not_active Application Discontinuation
- 1999-02-24 ID IDW20001594A patent/ID27280A/en unknown
- 1999-02-24 HU HU0100757A patent/HUP0100757A3/en unknown
- 1999-02-24 KR KR1020007009456A patent/KR20010041343A/en not_active Application Discontinuation
- 1999-02-24 EE EEP200000486A patent/EE200000486A/en unknown
- 1999-02-24 TR TR2000/02446T patent/TR200002446T2/en unknown
- 1999-02-24 EA EA200000868A patent/EA200000868A1/en unknown
-
2000
- 2000-08-23 NO NO20004220A patent/NO20004220L/en unknown
- 2000-08-24 HR HR20000552A patent/HRP20000552A2/en not_active Application Discontinuation
- 2000-09-19 BG BG104780A patent/BG104780A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO20004220D0 (en) | 2000-08-23 |
EP1056719A2 (en) | 2000-12-06 |
TR200002446T2 (en) | 2000-12-21 |
NO20004220L (en) | 2000-10-05 |
WO1999043651A2 (en) | 1999-09-02 |
JP2002504539A (en) | 2002-02-12 |
SK12742000A3 (en) | 2001-05-10 |
HUP0100757A1 (en) | 2001-08-28 |
ID27280A (en) | 2001-03-22 |
KR20010041343A (en) | 2001-05-15 |
IL137718A0 (en) | 2001-10-31 |
HUP0100757A3 (en) | 2001-11-28 |
CA2322161A1 (en) | 1999-09-02 |
CN1299347A (en) | 2001-06-13 |
BG104780A (en) | 2001-10-31 |
EA200000868A1 (en) | 2001-04-23 |
HRP20000552A2 (en) | 2001-04-30 |
WO1999043651A3 (en) | 1999-12-16 |
PL342995A1 (en) | 2001-07-16 |
EE200000486A (en) | 2002-02-15 |
AU2782699A (en) | 1999-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9908280A (en) | Phospholipase enzyme inhibitors | |
BR9909242A (en) | A2 phospholipase inhibitors | |
DK0966465T3 (en) | Inhibitors of IMPDH enzymes | |
MY129998A (en) | Saccharin derivative proteolytic enzyme inhibitors | |
MX9207449A (en) | INHIBITORS OF THE PROTEOLYTIC ENZYME DERIVED FROM SACARINE. | |
EA200100589A1 (en) | AZABICYL ALKANS AS CCR5 MODULATORS | |
TR199901191T2 (en) | Use of benzamidoaldehydes as cysteine protease inhibitors. | |
DE69905476D1 (en) | Phosphonsaürederivate als ptp-1b-inhibitoren | |
RS50091B (en) | Use of retigabine for the treatment of neuropathic pain | |
EE200000488A (en) | Phospholipase enzyme inhibitors and pharmaceutical compositions | |
ES2172657T3 (en) | THROMBIN INHIBITORS. | |
DE50014190D1 (en) | USE OF PHTHALAZINE DERIVATIVES FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
BR9810870A (en) | Regulation of quinolate phosphoribosyl transferase expression | |
ATE225772T1 (en) | THROMBIN INHIBITORS | |
TR199900310T2 (en) | Thrombin inhibitors | |
ATE290857T1 (en) | BRETYLIUM-CONTAINING COMPOSITIONS AND KITS AND THE USE THEREOF FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES | |
BR9814188A (en) | "5-ht1f agonists" | |
BR9909237A (en) | Farnesyl-protein transferase inhibitors | |
ATE305517T1 (en) | NEUROTRYPSIN | |
IL139144A0 (en) | Mycobacterial inhibitors | |
AUPP345098A0 (en) | Novel anti-fibrinolytic agents | |
SE0302965D0 (en) | Inhibitors of DNA methyltransferase isoforms | |
MXPA03001986A (en) | Antithrombotic compositions. | |
BR9907697A (en) | Serine carbonates | |
BR9803717A (en) | indole-2-carbocyclic acids substituted as glucosyl transferase inhibitors. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTA A 6O, 7O E 8O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |